Condition

Biliary Tract Neoplasms (1)

Carcinoma, Non-Small-Cell Lung (1)

HER2 Mutations Breast Neoplasms (1)

Urologic Neoplasms (1)

Uterine Cervical Neoplasms (1)

Uterine Neoplasms (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Seagen Inc. (1)

Collaborator

Intervention

fulvestrant (1)

trastuzumab (1)

tucatinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

her2 mutations breast neoplasms

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Uterine Tumors, Uterine Cervical Tumors, Biliary Tract Tumors Trial in Worldwide (tucatinib, trastuzumab, fulvestrant)

Recruiting

Uterine Neoplasms
+5 more

tucatinib
+2 more

Goodyear, Arizona
+63 more

Aug 15, 2022